NYSE:AZN - AstraZeneca SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$42.87 +0.29 (+0.68 %)
(As of 03/20/2019 03:49 AM ET)
Previous Close$42.58
Today's Range$42.73 - $43.06
52-Week Range$34.11 - $43.06
Volume3.21 million shs
Average Volume5.22 million shs
Market Capitalization$108.59 billion
P/E Ratio12.39
Dividend Yield4.37%
Beta0.52

SEC Filings

AstraZeneca (NYSE:AZN) SEC Filings

DateFilerForm TypeView
03/18/2019
5:34 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/14/2019
7:44 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/14/2019
7:07 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/12/2019
7:41 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/06/2019
6:49 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/05/2019
3:40 PM
AstraZeneca (Filer)
Form IRANNOTICE
View Filing
03/05/2019
5:40 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/01/2019
10:21 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/01/2019
10:16 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/26/2019
5:34 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/25/2019
6:26 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/14/2019
11:55 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/12/2019
8:34 AM
AstraZeneca (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
02/06/2019
5:47 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/05/2019
5:16 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/05/2019
5:10 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/01/2019
9:50 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/01/2019
8:03 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/30/2019
5:02 AM
AstraZeneca (Filed by)
Moderna, Inc. (Subject)
Form SC 13G
View Filing
01/25/2019
8:47 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/07/2019
8:46 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/02/2019
11:37 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/20/2018
9:38 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/20/2018
5:33 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/20/2018
5:20 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/19/2018
12:57 PM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/18/2018
5:25 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/14/2018
5:43 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/07/2018
5:41 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/06/2018
7:06 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/04/2018
10:15 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/03/2018
10:55 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/03/2018
10:48 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/03/2018
6:57 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/26/2018
6:49 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/16/2018
1:55 PM
AstraZeneca (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
View Filing
11/16/2018
1:54 PM
AstraZeneca (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
View Filing
11/16/2018
5:23 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/13/2018
7:39 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/13/2018
5:45 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/13/2018
5:21 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/08/2018
5:31 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/06/2018
5:20 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/01/2018
11:37 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/31/2018
6:17 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/30/2018
5:38 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/29/2018
12:03 PM
AstraZeneca (Filed by)
PhaseBio Pharmaceuticals Inc (Subject)
Form SC 13D
View Filing
10/24/2018
3:16 PM
AstraZeneca (Reporting)
PhaseBio Pharmaceuticals Inc (Issuer)
Zeneca, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/23/2018
5:28 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/22/2018
5:35 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/19/2018
7:42 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/17/2018
6:44 PM
AstraZeneca (Reporting)
PhaseBio Pharmaceuticals Inc (Issuer)
Zeneca, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/16/2018
6:11 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/12/2018
10:10 AM
AstraZeneca (Filed by)
Entasis Therapeutics Holdings Inc. (Subject)
Form SC 13D/A
View Filing
10/05/2018
12:36 PM
AstraZeneca (Filed by)
Entasis Therapeutics Holdings Inc. (Subject)
Form SC 13D
View Filing
10/02/2018
8:35 PM
ASTRAZENECA AB (Reporting)
AstraZeneca (Reporting)
Entasis Therapeutics Holdings Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/01/2018
10:07 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/30/2018
11:00 PM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/28/2018
10:22 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/25/2018
7:34 PM
ASTRAZENECA AB (Reporting)
AstraZeneca (Reporting)
Entasis Therapeutics Holdings Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/25/2018
7:27 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/24/2018
10:54 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/24/2018
5:21 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/14/2018
6:07 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/07/2018
5:28 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/06/2018
5:50 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/04/2018
6:05 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/31/2018
6:05 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/30/2018
6:23 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/23/2018
8:42 AM
AstraZeneca (Filer)
Form CERT
View Filing
08/23/2018
5:56 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/21/2018
5:28 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/17/2018
2:36 PM
AstraZeneca (Filer)
Form 8-A12B
View Filing
08/17/2018
2:12 PM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/16/2018
11:33 AM
AstraZeneca (Filer)
Form 424B2
View Filing
08/15/2018
5:19 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/14/2018
3:14 PM
AstraZeneca (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
08/14/2018
7:22 AM
AstraZeneca (Subject)
Form FWP
View Filing
08/14/2018
7:18 AM
AstraZeneca (Filer)
Form 424B2
View Filing
08/10/2018
5:19 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/03/2018
5:55 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/01/2018
11:10 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/27/2018
10:39 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/26/2018
9:28 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/24/2018
6:18 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/18/2018
7:12 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/03/2018
2:39 PM
AstraZeneca (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
View Filing
07/02/2018
10:36 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/02/2018
5:50 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/02/2018
5:41 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/28/2018
7:58 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/27/2018
5:54 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/26/2018
5:29 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/22/2018
5:15 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/12/2018
7:19 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/08/2018
12:27 PM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/08/2018
6:59 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/01/2018
10:15 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/01/2018
10:14 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/01/2018
7:29 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel